ÂÜÀòÂÒÂ×

Log inSign up

Vericel

0 followers

‌

Vericel (NASDAQ:VCEL) develops, manufactures and markets autologous expanded cell therapies for the treatment of patients with serious diseases and conditions

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Dominick Colangelo
President & CEO

Dominick Colangelo

Collapse
Joe Mara
CFO
Jonathan Hopper
Chief Medical Officer
Sean Flynn
SVP, General Counsel & Secretary
Mike Halpin
SVP, Quality & Regulatory Affairs
Patrick Fowler
SVP, Corporate Development & Strategy
Roland DeAngelis
SVP, Commercial Operations
Doug Kennedy
SVP, Operations
Heidi Hassen
SVP, Human Resources
Shannon Kelly
VP, Burn Care National Sales
Caryn Crame
VP, Clinical Affairs & Epidemiology
Mike Gilligan
VP, MACI Sales
Adrian Lowe
VP, Manufacturing
Cindy Entstrasser
VP, Quality
Patrick Helfrich
VP, Marketing & Commercial Strategy
Demet Durak
Senior Executive Assistant To The CEO

Teams

+28

Sales and Marketing

31 members

+12

Clinical and Medical Affairs

15 members

+9

Operations and Development Team

12 members

+6

Quality and Regulatory

9 members

+6

Directors Team

9 members

+5

Finance and Accounting

8 members

Similar companies

SpringWorks Therapeutics

5 followers

Halozyme Therapeutics

4 followers

Prime Medicine

3 followers

Generation Bio

2 followers

Celldex Therapeutics

2 followers

Rigel Pharmaceuticals

2 followers

Viridian Therapeutics

2 followers

Modern Meadow

2 followers

Vividion Therapeutics

1 follower

Mersana Therapeutics

1 follower

ReCode Therapeutics

1 follower

Explore companies